You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PR069/#709  Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study

Article metrics

Article menu

Download PDFPDF

Featured Posters: Poster Rounds with the Professors
AS11. Ovarian cancer
PR069/#709  Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 20233509
Dec 202355010
Jan 20242403
Feb 20241800
Mar 20242307
Apr 20241604
May 20241501
Jun 20242200
Jul 20241002
Aug 2024805
Sep 20241000
Total236041